Immunology and Microbiology
Transplant Procedure
100%
BK Virus
86%
Severe Acute Respiratory Syndrome Coronavirus 2
84%
Viral Load
71%
Kidney Transplantation
54%
Immunosuppressive Drug
39%
Mycophenolic Acid
36%
Infectious Agent
36%
Real-Time Polymerase Chain Reaction
36%
Torque Teno Virus 1
36%
COVID-19
36%
Blood Plasma
35%
Polymerase Chain Reaction
30%
Real Time Polymerase Chain Reaction
30%
Viremia
28%
Ciclosporin
27%
Nucleic Acid Amplification
24%
Viral Disease
22%
Tacrolimus
22%
Genotype
21%
Multiplex Polymerase Chain Reaction
20%
Immunosuppressive Therapy
18%
Enterovirus
18%
Human Parainfluenza Virus 3
18%
Cell Culture
18%
Glomerulus Filtration
18%
Human Cytomegalovirus
18%
Everolimus
18%
Vaccine Efficacy
18%
Low Drug Dose
18%
Septic Arthritis
18%
Molecular Epidemiology
18%
Hepatitis E Virus
18%
Immunosuppression
18%
Kidney Function
18%
Cytomegalovirus
18%
Dynamics
18%
Vaccination Policy
17%
Reverse Transcription Polymerase Chain Reaction
16%
Organ Transplantation
15%
Serotype
11%
Prednisolone
10%
Immune System
10%
Storage Temperature
9%
Synovial Fluid
9%
Arthroplasty
9%
Microorganism
9%
RNA Extraction
9%
Allotransplantation
9%
Cell Lysate
9%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
71%
Kidney Graft
54%
Pathogen
54%
Immunosuppressive Treatment
54%
BK Virus
45%
COVID-19
38%
Infection
37%
Mycophenolic Acid
36%
Kidney Transplantation
31%
Patient Care
31%
Cyclosporine
27%
Nephropathy
24%
Quality of Life
22%
Virus Infection
22%
Immunosuppressive Drug
21%
Multiplex Polymerase Chain Reaction
20%
Prospective Cohort Study
20%
Cell Culture
18%
Cytomegalovirus
18%
Human Cytomegalovirus
18%
Everolimus
18%
Randomized Controlled Trial
18%
Cohort Effect
18%
Low Drug Dose
18%
Periprosthetic Joint Infection
18%
Cluster Analysis
18%
Molecular Epidemiology
18%
Nucleic Acid
18%
Intensive Care Unit
18%
Molecular Diagnosis
18%
Glomerular Filtration Rate
18%
Polyomavirus Infection
18%
Adult Hematology
18%
Infection Control
18%
Enterovirus
18%
Retrospective Cohort Study
18%
Transplantation
18%
Allograft
18%
Human Parainfluenza Virus 3
18%
Virus DNA
18%
Post-COVID-19
18%
Prevalence
18%
Kidney Function
18%
Immunocompromised Patient
18%
Infectious Arthritis
18%
Polymerase Chain Reaction
15%
Sputum
14%
Tacrolimus
13%
Biopsy
13%
Diagnosis
13%
Keyphrases
Quantitative PCR
38%
Quality Control
36%
Multinational Clinical Trials
36%
Laboratory Standards
36%
Torque Teno Virus
36%
Renal Transplantation
31%
BK Polyomavirus (BKPyV)
27%
Trial Phase
27%
Interlaboratory
27%
Intra-laboratory
27%
External Quality Assessment
27%
Internal Quality Control
27%
Viral Infection
22%
Pretransplant
21%
BKPyVAN
19%
Multiplex PCR Panels
18%
Gamma Variant
18%
Beta Variant
18%
Nucleic Acid-based Techniques
18%
RealAmp
18%
ELITe InGenius
18%
BioFire FilmArray
18%
QIAstat-Dx
18%
School Reopening
18%
Molecular Diagnostics
18%
In-house PCR
18%
Cytomegalovirus
18%
Human Cytomegalovirus
18%
Bovine Parainfluenza Virus Type 3 (BPIV3)
18%
Genotype
18%
Renal Transplant Recipients
18%
Kidney Transplantation
18%
DNAemia
18%
Viral Load Dynamics
18%
Renal Function
18%
Virus Load
18%
Trough Level
18%
Implementation Process
18%
Viral RNA Shedding
18%
Immunosuppressive Drugs
13%
Diagnostic Test
13%
BK Viruria
12%
HEV RNA
10%
Estimated Glomerular Filtration Rate
9%
Load Detection
9%
Secondary Reference Materials
9%
Calibrant
9%
Transplant Outcomes
9%
WHO International Standard
9%
COVID-19 Outpatients
9%
